0001288469-19-000188.txt : 20191122
0001288469-19-000188.hdr.sgml : 20191122
20191122160946
ACCESSION NUMBER: 0001288469-19-000188
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191120
FILED AS OF DATE: 20191122
DATE AS OF CHANGE: 20191122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LITCHFIELD STEVEN G
CENTRAL INDEX KEY: 0001286030
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34666
FILM NUMBER: 191241641
MAIL ADDRESS:
STREET 1: C/O MAXLINEAR, INC.
STREET 2: 5966 LA PLACE COURT, SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92008
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MAXLINEAR INC
CENTRAL INDEX KEY: 0001288469
STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674]
IRS NUMBER: 141896129
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5966 LA PLACE CT.
CITY: CARLSBAD
STATE: CA
ZIP: 92008
BUSINESS PHONE: 760-692-0711
MAIL ADDRESS:
STREET 1: 5966 LA PLACE CT.
CITY: CARLSBAD
STATE: CA
ZIP: 92008
4
1
wf-form4_157445697081449.xml
FORM 4
X0306
4
2019-11-20
0
0001288469
MAXLINEAR INC
MXL
0001286030
LITCHFIELD STEVEN G
C/O MAXLINEAR, INC.
5966 LA PLACE COURT, SUITE 100
CARLSBAD
CA
92008
0
1
0
0
See remarks
Common Stock
2019-11-20
4
M
0
1123
0
A
59950
D
Common Stock
2019-11-20
4
F
0
1123
19.99
D
58827
D
Restricted Stock Units
2019-11-20
4
M
0
1123
0
D
Common Stock
1123.0
35750
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of MaxLinear, Inc. Common Stock.
Includes 1,012 shares of Common Stock acquired under the Company's 2010 Employee Stock Purchase Plan on November 15, 2019.
Subject to the Reporting Person's continuing to be a Service Provider (as defined in the 2010 Equity Incentive Plan) through each applicable vesting date, twenty-five percent (25%) of the 52,000 RSUs subject to the award shall vest on August 20, 2019, and an additional one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each November 20, February 20, May 20, and August 20 thereafter, such that the award will be fully vested on August 20, 2022.
Chief Financial Officer and Chief Corporate Strategy Officer
/s/ Connie Kwong, as Attorney-in-Fact
2019-11-22